(Q43645713)

English

Analysis of the relative costs and effectiveness of primary angioplasty versus tissue-type plasminogen activator: the Primary Angioplasty in Myocardial Infarction (PAMI) trial. The PAMI Trial Investigators

scientific article published in April 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 November 2017

Analysis of the relative costs and effectiveness of primary angioplasty versus tissue-type plasminogen activator: the Primary Angioplasty in Myocardial Infarction (PAMI) trial. The PAMI Trial Investigators (English)

1 reference

Europe PubMed Central

25 November 2017

myocardial infarction

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1

object named as

Stone GW

1 reference

Europe PubMed Central

25 November 2017

author name string

Grines CL

2

1 reference

Europe PubMed Central

25 November 2017

Rothbaum D

3

1 reference

Europe PubMed Central

25 November 2017

Browne KF

4

1 reference

Europe PubMed Central

25 November 2017

O'Keefe J

5

1 reference

Europe PubMed Central

25 November 2017

Overlie PA

6

1 reference

Europe PubMed Central

25 November 2017

Donohue BC

7

1 reference

Europe PubMed Central

25 November 2017

Chelliah N

8

1 reference

Europe PubMed Central

25 November 2017

Vlietstra R

9

1 reference

Europe PubMed Central

25 November 2017

Catlin T

10

1 reference

Europe PubMed Central

25 November 2017

O'Neill WW

11

1 reference

Europe PubMed Central

25 November 2017

language of work or name

0 references

publication date

1 April 1997

1 reference

Europe PubMed Central

25 November 2017

Journal of the American College of Cardiology

1 reference

Europe PubMed Central

25 November 2017

29

1 reference

Europe PubMed Central

25 November 2017

5

1 reference

Europe PubMed Central

25 November 2017

901-907

1 reference

Europe PubMed Central

25 November 2017

A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictors of in-hospital and 6-month outcome after acute myocardial infarction in the reperfusion era: the Primary Angioplasty in Myocardial Infarction (PAMI) trail

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. The Mayo Coronary Care Unit and Catheterization Laboratory Groups

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Baseline and 6-month costs of primary angioplasty therapy for acute myocardial infarction: results from the primary angioplasty registry.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Implications of recurrent ischemia after reperfusion therapy in acute myocardial infarction: a comparison of thrombolytic therapy and primary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of in-hospital outcome in men versus women treated by either thrombolytic therapy or primary coronary angioplasty for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of acute myocardial infarction location on in-hospital and late outcome after primary percutaneous transluminal coronary angioplasty versus tissue plasminogen activator therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A cost-effective analysis of primary coronary angioplasty versus thrombolysis for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The distinction between cost and charges

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost comparison of immediate angioplasty versus thrombolysis followed by conservative therapy for acute myocardial infarction: a randomized prospective trial. Mayo Coronary Care Unit and Catheterization Laboratory Groups

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The cost of an open infarct-related artery: comparison of treatment modalities in the reperfusion era

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Recurrent ischemia without warning. Analysis of risk factors for in-hospital ischemic events following successful thrombolysis with intravenous tissue plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized controlled trial of hospital discharge three days after myocardial infarction in the era of reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of acute myocardial infarction patients suitable for early hospital discharge after aggressive interventional therapy. Results from the Thrombolysis and Angioplasty in Acute Myocardial Infarction Registry

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0735-1097(97)00041-7

1 reference

Europe PubMed Central

25 November 2017

1 reference

Europe PubMed Central

25 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43645713&oldid=2102294219"